Raymond Debbane - 01 Aug 2022 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Issuer symbol
LXRX
Transactions as of
01 Aug 2022
Net transactions value
+$2,456,500
Form type
4
Filing time
01 Aug 2022, 16:13:38 UTC
Previous filing
06 Jul 2022
Next filing
05 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Purchase $2,456,500 +982,600 +23% $2.50 5,303,814 01 Aug 2022 By Invus US Partners LLC
holding LXRX Common Stock 331,545 01 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.